{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:06:05Z","timestamp":1792667165978,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T00:00:00Z","timestamp":1248825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00296-009-1067-4","type":"journal-article","created":{"date-parts":[[2009,7,28]],"date-time":"2009-07-28T11:51:19Z","timestamp":1248781879000},"page":"779-784","source":"Crossref","is-referenced-by-count":32,"title":["Increased plasma myeloperoxidase levels in systemic lupus erythematosus"],"prefix":"10.1007","volume":"30","author":[{"given":"Rosa Weiss","family":"Telles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda Aparecida","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neusa Pereira da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia Inoue","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,29]]},"reference":[{"key":"1067_CR1","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/art.21130","volume":"52","author":"PE Morgan","year":"2005","unstructured":"Morgan PE, Sturgess AD, Davies MJ (2005) Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum 52:2069\u20132079","journal-title":"Arthritis Rheum"},{"key":"1067_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0891-5849(96)00283-3","volume":"22","author":"MS Cooke","year":"1997","unstructured":"Cooke MS, Mistry N, Wood C et al (1997) Immunogenicity of DNA damage by reactive oxygen species: implications for anti-DNA antibodies in lupus. Free Radic Biol Med 22:151\u2013159","journal-title":"Free Radic Biol Med"},{"key":"1067_CR3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1191\/096120300678828280","volume":"9","author":"O Vaarala","year":"2000","unstructured":"Vaarala O (2000) Antibodies to oxidised LDL. Lupus 9:202\u2013205","journal-title":"Lupus"},{"key":"1067_CR4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.abb.2005.10.015","volume":"445","author":"C Obinger","year":"2006","unstructured":"Obinger C (2006) Chemistry and biology of human peroxidases. Arch Biochem Biophys 445:197\u2013198","journal-title":"Arch Biochem Biophys"},{"key":"1067_CR5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0009-2797(00)00201-5","volume":"129","author":"PJ O\u2019Brien","year":"2000","unstructured":"O\u2019Brien PJ (2000) Peroxidases. Chem Biol Interact 129:113\u2013139","journal-title":"Chem Biol Interact"},{"key":"1067_CR6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00467-007-0475-5","volume":"22","author":"A Ece","year":"2007","unstructured":"Ece A, Kelek\u00e7i S, Hekimoglu A et al (2007) Neutrophil activation, protein oxidation and ceruloplasmin levels in children with Henoch-Schonlein purpura. Pediatr Nephrol 22:1151\u20131157","journal-title":"Pediatr Nephrol"},{"key":"1067_CR7","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685\u20131695","journal-title":"N Engl J Med"},{"key":"1067_CR8","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","volume":"349","author":"M-L Brennan","year":"2003","unstructured":"Brennan M-L, Penn MS, Lente FV et al (2003) Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349:1595\u20131604","journal-title":"N Engl J Med"},{"key":"1067_CR9","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","volume":"286","author":"R Zhang","year":"2001","unstructured":"Zhang R, Brennan M-L, Fu X et al (2001) Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286:2136\u20132142","journal-title":"JAMA"},{"key":"1067_CR10","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1046\/j.1523-1755.2003.00336.x","volume":"64","author":"E Malle","year":"2003","unstructured":"Malle E, Buch T, Grone H-J (2003) Myeloperoxidase in kidney disease. Kidney Int 64:1956\u20131967","journal-title":"Kidney Int"},{"key":"1067_CR11","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/hep.1840380428","volume":"38","author":"CT Wu","year":"2003","unstructured":"Wu CT, Eiserich JP, Ansari AA et al (2003) Myeloperoxidase-positive inflammatory cells participate in the bile duct in primary biliary cirrhosis through nitric oxide-mediated reactions. Hepatology 38:1018\u20131025","journal-title":"Hepatology"},{"key":"1067_CR12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/030097499442559","volume":"28","author":"S Minota","year":"1999","unstructured":"Minota S, Horie S, Yamada A et al (1999) Circulating myeloperoxidase and anti-myeloperoxidase antibody in patients with vasculitis. Scand J Rheumatol 28:94\u201399","journal-title":"Scand J Rheumatol"},{"key":"1067_CR13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1164\/ajrccm.161.2.9904076","volume":"161","author":"A Schnabel","year":"2000","unstructured":"Schnabel A, Csernok E, Braun J et al (2000) Activation of neutrophils, eosinophils, and lymphocytes in the lower respiratory tract in Wegner\u2019s Granulomatosis. Am J Respir Crit Care Med 161:399\u2013405","journal-title":"Am J Respir Crit Care Med"},{"key":"1067_CR14","first-page":"495","volume":"18","author":"A Accardo-Palumbo","year":"2000","unstructured":"Accardo-Palumbo A, Triolo G, Carbone MC et al (2000) Polymorphonuclear leukocyte myeloperoxidase levels in patients with Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 18:495\u2013498","journal-title":"Clin Exp Rheumatol"},{"key":"1067_CR15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2004.06003.x","volume":"151","author":"C Yazici","year":"2004","unstructured":"Yazici C, Kose K, Calis M et al (2004) Increased advanced oxidation protein products in Behcet\u2019s disease: a new activity marker? Br J Dermatol 151:105\u2013111","journal-title":"Br J Dermatol"},{"key":"1067_CR16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cccn.2003.12.030","volume":"343","author":"M Milovanovic","year":"2004","unstructured":"Milovanovic M, Nilsson E, Jaremo P (2004) Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta 343:237\u2013240","journal-title":"Clin Chim Acta"},{"key":"1067_CR17","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/rheumatology\/keh317","volume":"43","author":"C Yazici","year":"2004","unstructured":"Yazici C, Kose K, Calis M et al (2004) Protein oxidation status in patients with ankylosing spondylitis. Rheumatology 43:1235\u20131239","journal-title":"Rheumatology"},{"key":"1067_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1189\/jlb.1202611","volume":"74","author":"AA Rarok","year":"2003","unstructured":"Rarok AA, Limburg PC, Kallenberg CG (2003) Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol 74:3\u201315","journal-title":"J Leukoc Biol"},{"key":"1067_CR19","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1182\/blood.V96.8.2822","volume":"96","author":"C Hess","year":"2000","unstructured":"Hess C, Sadallah S, Schifferli JA (2000) Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils. Blood 96:2822\u20132827","journal-title":"Blood"},{"key":"1067_CR20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1191\/0961203303lu456rr","volume":"12","author":"D Sen","year":"2003","unstructured":"Sen D, Isenberg DA (2003) Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus 12:651\u2013658","journal-title":"Lupus"},{"key":"1067_CR21","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of the systemic lupus erythematosus (letter). Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"1067_CR22","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288\u2013291","journal-title":"J Rheumatol"},{"key":"1067_CR23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0165-2478(01)00220-6","volume":"77","author":"H la Fuente De","year":"2001","unstructured":"De la Fuente H, Richard-Patin Y, Jakez-Ocampo J et al (2001) Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus. Immunol Lett 77:175\u2013180","journal-title":"Immunol Lett"},{"key":"1067_CR24","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/art.11237","volume":"48","author":"Y Ren","year":"2003","unstructured":"Ren Y, Tang J, Mok MY et al (2003) Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 48:2888\u20132897","journal-title":"Arthritis Rheum"},{"key":"1067_CR25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-2143(99)90061-6","volume":"133","author":"JW Heinecke","year":"1999","unstructured":"Heinecke JW (1999) Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. Lab Clin Med 133:321\u2013325","journal-title":"Lab Clin Med"},{"key":"1067_CR26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1196\/annals.1422.016","volume":"1108","author":"JR Batuca","year":"2007","unstructured":"Batuca JR, Ames PR, Isenberg DA et al (2007) Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus. Ann N Y Acad Sci 1108:137\u2013146","journal-title":"Ann N Y Acad Sci"},{"key":"1067_CR27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1073\/pnas.0405193102","volume":"102","author":"D Lau","year":"2005","unstructured":"Lau D, Mollnau H, Eiserich JP et al (2005) Myeloperoxidase mediates neutrophil activation by association with CD11b\/CD18 integrins. PNAS 102:431\u2013436","journal-title":"PNAS"},{"key":"1067_CR28","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/rheumatology\/38.12.1249","volume":"38","author":"I Torsteinsdottir","year":"1999","unstructured":"Torsteinsdottir I, Hakansson L, Hallgren R et al (1999) Serum lysozyme: a potential marker of monocyte\/macrophage activity in rheumatoid arthritis. Rheumatology 38:1249\u20131254","journal-title":"Rheumatology"},{"key":"1067_CR29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0753-3322(89)90190-X","volume":"43","author":"J Fontagne","year":"1889","unstructured":"Fontagne J, Roch-Arveiller M, Giroud JP et al (1889) Effects of some antimalarial drugs on rat inflammatory polymorphonuclear leukocyte function. Biomed Pharmacother 43:43\u201351","journal-title":"Biomed Pharmacother"},{"issue":"Suppl 1","key":"1067_CR30","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1177\/0961203396005001031","volume":"5","author":"R Fox","year":"1996","unstructured":"Fox R (1996) Antimalarial drugs: possible mechanism of action in autoimmune disease and prospects for drug development. Lupus 5(Suppl 1):S4\u2013S10","journal-title":"Lupus"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1067-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-1067-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1067-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T01:25:29Z","timestamp":1590024329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-1067-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,29]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-1067-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,29]]}}}